Business Wire

SES

5.4.2022 14:03:04 CEST | Business Wire | Press release

Share
Satellite Monitor Annual Research Shows SES Increase Reach to 366 Million TV Homes Worldwide

SES announced today the results of its annual Satellite Monitor market research, the industry’s premier accounting of satellite’s TV reach, which underscores SES’s position as the leader in enabling content delivery via satellite directly and indirectly. SES now delivers almost 8,400 TV channels – including 3,130 in HD or UHD – to a total of 366 million TV homes worldwide, an increase of five million homes over the previous year. SES continues to outperform the industry with the highest number of TV homes reached and record-breaking number of channels delivered.

The increase of TV households served by SES can be attributed to the growing reach in Africa (+9.1 million), APAC (+1 million) and Latin America (+1.7 million), where direct-to-home satellite platforms and IPTV continue to gain traction as leading TV reception methods. In SES’s key European market via 19.2 degrees East, SES continues to reach 117 million homes, delivering content to half of all TV homes in the market via satellite, cable or IPTV. SES’s reach to TV homes in North America is down by 6 million as American audiences turn toward online streaming alternatives.

In Africa, SES continues to expand its satellite reach due to the growth of Ethiopian free-to-air offering, including the country’s first dedicated TV platform Ethiosat. SES has also led an intensive programme to get TV viewers in Ethiopia to repoint their dishes at the satellite positioned at 57 degrees East for the past two years, and is currently serving a predominant number of satellite TV homes in Ethiopia.

The following table shows the 2021 Satellite Monitor regional breakdown of SES’s TV home reach:

Market

TV Homes

Europe

170 million

North America

59 million

Africa

46 million

Latin America

44 million

Asia Pacific

34 million

Middle East

13 million

Additionally, key trends have been identified in African and European markets:

  • TV home evolution in Africa – TV penetration across markets in Africa, such as Ethiopia, Nigeria and Ghana, has soared by 27% since 2017 as satellite gains popularity as the leading means of TV reception
  • Free-to-air in Europe – As more turn to over-the-top TV (OTT) packages, free-to-air satellite TV remains stable in Europe over the last five years, underscoring the value proposition of satellite TV and the complementary nature of OTT
  • IPTV growth – Internet protocol television (IPTV) continues to grow across Europe as an emerging distribution method, whereas terrestrial television (DTT) declined.

"For almost three decades we have been publishing the Satellite Monitor market research on a yearly basis, enabling our video customers from all over the world to leverage the impartial data to make informed decisions about their business. These additional insights, combined with our premium fleet of satellites’ ability to deliver content in the most cost-effective way to the widest possible audiences, demonstrate why leading broadcasters continue to extend and expand their partnerships with us. This underscores the solidity of our video business for the years to come,” said Deepak Mathur, Executive Vice President of Global Video Sales at SES.

For 28 years, SES’s Satellite Monitor has been a key industry benchmark report conducted by leading market research institutes to analyse the market dynamics (TV reception, resolution, devices, etc.), reach (by country, orbital position and reception mode) and social demographics.

Follow us on:

Twitter | Facebook | YouTube | LinkedIn | Instagram

Read our Blogs >
Visit the Media Gallery >

About SES

SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries 8,400 channels and has an unparalleled reach of 366 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com .

Link:

ClickThru

Social Media:

https://www.facebook.com/SES.Satellites/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Zambon Announces European Commission Approval of Hopledo® for Adults with Parkinson's Disease and Moderate to Severe Motor Fluctuations28.8.2026 11:00:00 CEST | Press release

Hopledo® is a first-in-class, oral, modified-release formulation of levodopa/carbidopa (LD/CD) approved for the treatment of motor fluctuations of Parkinson’s disease Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026 The approval is based on data from the Phase 3 RISE-PD trial where Hopledo® demonstrated a significant increase in Good ON time compared with immediate-release LD/CD with fewer daily doses and a comparable safety profile Zambon today announced that the European Commission (EC) has granted marketing authorization for Hopledo® (modified-release levodopa/carbidopa) for the treatment of adult patients with Parkinson’s disease and moderate to severe motor fluctuations who have not been sufficiently stabilized with oral levodopa/dopa decarboxylase (DDC) inhibitor-based treatment regimens. Zambon expects to begin the phased introduction of Hopledo® across European markets starting October 2026. The company is working closely

MTG-I2 Safely in Orbit, Unlocking Faster and Sharper Weather Monitoring Across Europe28.8.2026 10:16:00 CEST | Press release

The Meteosat Third Generation Imager 2 satellite (MTG-I2) has successfully passed its first critical post-launch milestones, completing the first full Meteosat Third Generation constellation in orbit. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260828243790/en/ Credit: Arianespace livestream The imager satellite MTG-I2 is safely in orbit and operating as expected following its successful launch yesterday at 22:11 CEST on board an Ariane 6 rocket from Europe’s Spaceport in French Guiana. Our teams have established communication with the spacecraft, which has also deployed its solar panels to ensure its autonomous production of energy. MTG-I2 is in perfect shape to start its Launch and Early Operations Phase that will bring it to a higher orbit, 36 000km above Earth over the following two weeks, where a longer period of calibration and validation of its instruments will begin. This summer’s extreme weather and wildfires hav

New Daiichi Sankyo Data Underscore the Effect of Bempedoic Acid in the Real-World Management of Dyslipidemia and Cardiovascular risk28.8.2026 10:00:00 CEST | Press release

Analyses from the multinational MILOS study show that LDL-C reductions achieved with up to one year of treatment with bempedoic acid-containing therapies translate to a 17.1% relative reduction and a 4.8% absolute reduction in predicted 10-year cardiovascular risk.1 Real-world data demonstrated clinically relevant mean LDL-C reductions of at least 24.9%, regardless of patient gender or glycaemic status, after one year of follow-up.2,3 Findings presented at ESC Congress 2026 reinforce the clinical value of bempedoic acid in routine clinical practice, and demonstrate the continued investment of Daiichi Sankyo in addressing outstanding unmet needs in cardiovascular disease (CVD). Daiichi Sankyo (TSE:4568) today announced new results from the MILOS study that demonstrate the real-world impact of bempedoic acid administered either alone or as a fixed-dose combination with ezetimibe, in the management of dyslipidaemia. Presented at the European Society of Cardiology Congress 2026 in Munich,

TVS Motor Company Appoints Peyman Kargar as Director and Chief Executive Officer28.8.2026 09:31:00 CEST | Press release

Peyman Kargar appointed Director and Chief Executive Officer of TVS Motor Company, effective January 27, 2027 K. N. Radhakrishnan to continue as Director and Chief Executive Officer until then and subsequently will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027 Appointment supports TVS Motor Company's next phase of growth and innovation TVS Motor Company, part of TVS VENU and a leading global manufacturer of two and three-wheelers, today announced the appointment of Peyman Kargar as Director and Chief Executive Officer, effective January 27, 2027. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827012301/en/ Peyman Kargar Peyman will succeed K. N. Radhakrishnan, who will continue in his role until then to ensure a seamless transition. Following the transition, Radhakrishnan will serve as Non-Executive Director up to the date of the ensuing AGM scheduled in July 2027. He has been a

Philips and Imricor Launch Cardiac Interventional MR Lab Solution, Expanding Longstanding Collaboration27.8.2026 21:27:00 CEST | Press release

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Imricor Medical Systems (ASX: IMR), a pioneer and world-leading developer of MR-compatible products for interventional MR procedures, today announced a new Interventional MR (iMR) lab solution for Philips 1.5T MR. The first commercially available configuration* combines Philips’ 1.5T MRI platform and Imricor's portfolio of iMR systems and consumables, enabling an MR-guided workflow for cardiac intervention, without compromising on MR field strength. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260827693715/en/ Meeting the need for greater tissue insight during cardiac intervention Cardiac arrhythmias affect millions of people worldwide, and catheter ablation is an established and increasingly utilized treatment for many complex cardiac arrhythmias. Yet today, these procedures continue to rely primarily on X-ray fluoroscopy, which provides only

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye